Stuart Connolly in conversation with Thomas Lüscher
AVERROES: Apixaban Versus Acetylsalicyclic Acid (ASA) to Prevent Strokes.

Adriaan Voors in a conversation with Thomas Lüscher
HEBE III: A single dose of erhthropoietin in ST-elevation myocardial infarction.

Bertram Pitt in conversation with Frank Ruschitzka
PEARL HF: Multicentre, randomized, double-blind, placebo-controlled, parallel-group, mulitple-dose study to evaluate the effects of RLY5016 in heart failure patients.

Daan Kromhout in conversation with John Deanfield
ALPHA OMEGA: Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients.

Shinya Goto in conversation with Ulf Landmesser
Double-blind placebo controlled phase II studies of E5555 in Japanese patients with Acute Coronary Syndrome (ACS) and Coronary Artery Disease (CAD).

Michael Komajda in conversation with Frank Ruschitzka
SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction.

David Taggart in conversation with Ulf Landmesser
ART: A randomised trial to compare survival following bilateral versus single internal mammary (IMA) grafting in coronary revascularisation.